drugset / Trial / NCT04686825
The Food Effect on Pharmacokinetics of DA-8010 After a Single Administration of DA-8010 2.5 mg or 5 mg in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
This is a randomized, open-label, single-dose, 4-way crossover phase 1 study to evaluate the food effect on pharmacokinetics of DA-8010 after a single administration of DA-8010 2.5 mg or 5 mg under fasting and fed states in healthy male and female subjects
Timeline
- Start
- 2021-01-13
- Primary completion
- 2021-02-17
- Completion
- 2021-03-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VELUFENACIN | Small molecule | 2.5 mg | — |
| Subject | VELUFENACIN | Small molecule | 5 mg | — |
Indications
No indication recorded.